vs

Side-by-side financial comparison of MEDIFAST INC (MED) and OPAL Fuels Inc. (OPAL). Click either name above to swap in a different company.

OPAL Fuels Inc. is the larger business by last-quarter revenue ($88.4M vs $75.1M, roughly 1.2× MEDIFAST INC). On growth, OPAL Fuels Inc. posted the faster year-over-year revenue change (18.7% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-13.4M). Over the past eight quarters, OPAL Fuels Inc.'s revenue compounded faster (17.6% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

OPAL Fuels Inc. is a North American energy company focused on producing and distributing low-carbon renewable natural gas (RNG). It captures methane from landfills, dairy operations and other organic waste streams to produce RNG, which is mainly supplied to heavy-duty transportation fleets, commercial logistics operators and public transport entities to help reduce their greenhouse gas emissions.

MED vs OPAL — Head-to-Head

Bigger by revenue
OPAL
OPAL
1.2× larger
OPAL
$88.4M
$75.1M
MED
Growing faster (revenue YoY)
OPAL
OPAL
+55.6% gap
OPAL
18.7%
-36.9%
MED
More free cash flow
MED
MED
$6.7M more FCF
MED
$-6.6M
$-13.4M
OPAL
Faster 2-yr revenue CAGR
OPAL
OPAL
Annualised
OPAL
17.6%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
OPAL
OPAL
Revenue
$75.1M
$88.4M
Net Profit
$16.2M
Gross Margin
69.4%
Operating Margin
-10.4%
7.5%
Net Margin
18.3%
Revenue YoY
-36.9%
18.7%
Net Profit YoY
401.5%
EPS (diluted)
$-1.64
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
OPAL
OPAL
Q4 25
$75.1M
$88.4M
Q3 25
$89.4M
$77.9M
Q2 25
$105.6M
$77.4M
Q1 25
$115.7M
$83.0M
Q4 24
$119.0M
$74.5M
Q3 24
$140.2M
$82.6M
Q2 24
$168.6M
$69.8M
Q1 24
$174.7M
$64.0M
Net Profit
MED
MED
OPAL
OPAL
Q4 25
$16.2M
Q3 25
$-2.3M
$11.4M
Q2 25
$2.5M
$7.6M
Q1 25
$-772.0K
$1.3M
Q4 24
$-5.4M
Q3 24
$1.1M
$17.1M
Q2 24
$-8.2M
$1.9M
Q1 24
$8.3M
$677.0K
Gross Margin
MED
MED
OPAL
OPAL
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
OPAL
OPAL
Q4 25
-10.4%
7.5%
Q3 25
-4.6%
4.6%
Q2 25
-1.0%
-1.1%
Q1 25
-1.1%
-2.3%
Q4 24
0.6%
-0.5%
Q3 24
1.5%
14.9%
Q2 24
-4.7%
8.1%
Q1 24
4.5%
5.6%
Net Margin
MED
MED
OPAL
OPAL
Q4 25
18.3%
Q3 25
-2.5%
14.6%
Q2 25
2.3%
9.8%
Q1 25
-0.7%
1.5%
Q4 24
-7.2%
Q3 24
0.8%
20.7%
Q2 24
-4.8%
2.7%
Q1 24
4.8%
1.1%
EPS (diluted)
MED
MED
OPAL
OPAL
Q4 25
$-1.64
$0.08
Q3 25
$-0.21
$0.05
Q2 25
$0.22
$0.03
Q1 25
$-0.07
$-0.01
Q4 24
$0.08
$-0.05
Q3 24
$0.10
$0.09
Q2 24
$-0.75
$-0.01
Q1 24
$0.76
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
OPAL
OPAL
Cash + ST InvestmentsLiquidity on hand
$167.3M
$24.4M
Total DebtLower is stronger
$361.3M
Stockholders' EquityBook value
$198.9M
$-12.9M
Total Assets
$248.0M
$959.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
OPAL
OPAL
Q4 25
$167.3M
$24.4M
Q3 25
$173.5M
$29.9M
Q2 25
$162.7M
$29.3M
Q1 25
$164.6M
$40.1M
Q4 24
$162.3M
$24.3M
Q3 24
$170.0M
$31.0M
Q2 24
$163.5M
$27.6M
Q1 24
$156.4M
$34.2M
Total Debt
MED
MED
OPAL
OPAL
Q4 25
$361.3M
Q3 25
$351.2M
Q2 25
$331.6M
Q1 25
$307.0M
Q4 24
$307.5M
Q3 24
$252.9M
Q2 24
$233.3M
Q1 24
$208.7M
Stockholders' Equity
MED
MED
OPAL
OPAL
Q4 25
$198.9M
$-12.9M
Q3 25
$214.7M
$7.5M
Q2 25
$216.0M
$-25.0M
Q1 25
$211.0M
$57.1M
Q4 24
$210.1M
$-148.4M
Q3 24
$207.3M
$-180.1M
Q2 24
$205.3M
$-273.0M
Q1 24
$211.0M
$-382.4M
Total Assets
MED
MED
OPAL
OPAL
Q4 25
$248.0M
$959.5M
Q3 25
$268.2M
$916.7M
Q2 25
$269.3M
$905.5M
Q1 25
$280.0M
$884.9M
Q4 24
$284.2M
$881.1M
Q3 24
$291.2M
$831.1M
Q2 24
$293.5M
$782.3M
Q1 24
$302.8M
$750.5M
Debt / Equity
MED
MED
OPAL
OPAL
Q4 25
Q3 25
46.95×
Q2 25
Q1 25
5.38×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
OPAL
OPAL
Operating Cash FlowLast quarter
$-5.3M
$-3.5M
Free Cash FlowOCF − Capex
$-6.6M
$-13.4M
FCF MarginFCF / Revenue
-8.8%
-15.1%
Capex IntensityCapex / Revenue
1.8%
11.1%
Cash ConversionOCF / Net Profit
-0.22×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$-34.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
OPAL
OPAL
Q4 25
$-5.3M
$-3.5M
Q3 25
$12.1M
$18.2M
Q2 25
$-3.4M
$-7.9M
Q1 25
$3.4M
$29.7M
Q4 24
$-4.9M
$-532.0K
Q3 24
$9.1M
$17.7M
Q2 24
$13.1M
$533.0K
Q1 24
$7.3M
$13.7M
Free Cash Flow
MED
MED
OPAL
OPAL
Q4 25
$-6.6M
$-13.4M
Q3 25
$10.8M
$-9.3M
Q2 25
$-4.8M
$-29.7M
Q1 25
$1.9M
$18.1M
Q4 24
$-7.2M
$-55.0M
Q3 24
$7.7M
$-5.4M
Q2 24
$11.1M
$-22.5M
Q1 24
$5.4M
$-13.0M
FCF Margin
MED
MED
OPAL
OPAL
Q4 25
-8.8%
-15.1%
Q3 25
12.0%
-11.9%
Q2 25
-4.5%
-38.4%
Q1 25
1.6%
21.8%
Q4 24
-6.1%
-73.8%
Q3 24
5.5%
-6.5%
Q2 24
6.6%
-32.2%
Q1 24
3.1%
-20.4%
Capex Intensity
MED
MED
OPAL
OPAL
Q4 25
1.8%
11.1%
Q3 25
1.5%
35.3%
Q2 25
1.3%
28.2%
Q1 25
1.3%
13.9%
Q4 24
1.9%
73.1%
Q3 24
1.0%
27.9%
Q2 24
1.1%
32.9%
Q1 24
1.1%
41.8%
Cash Conversion
MED
MED
OPAL
OPAL
Q4 25
-0.22×
Q3 25
1.60×
Q2 25
-1.36×
-1.04×
Q1 25
23.11×
Q4 24
Q3 24
8.04×
1.03×
Q2 24
0.28×
Q1 24
0.88×
20.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

OPAL
OPAL

Fuel Station Services Segment$65.1M74%
Related Party$12.1M14%
Renewable Power Segment$8.6M10%
Other$2.6M3%

Related Comparisons